Regeneron Pharmaceuticals, Inc.
METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST

Last updated:

Abstract:

Methods for treating moderate-to-severe or severe atopic dermatitis in a pediatric subject are provided. In one aspect, the methods comprise administering to the subject one or more doses of an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof.

Status:
Application
Type:

Utility

Filling date:

5 Aug 2020

Issue date:

11 Feb 2021